Tacrolimus treatment of plasmacytoid dendritic cells inhibits dinucleotide (CpG-)-induced tumour necrosis factor-alpha secretion

Tacrolimus is a widely used immunosuppressive agent. Although T cells are the main targets of these pharmacological drugs, antigen presentation may also be affected. Among antigen-presenting cells, plasmacytoid dendritic cells (PDCs) are the main source of type I interferons upon microbial challenge...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Naranjo-Gómez, Mar, Climent, Nuria, Cos, Joan, Oliva, Harold, Bofill, Margarita, Gatell, José M, Gallart, Teresa, Pujol-Borrell, Ricardo, Borràs, Francesc E
Formato: Artigo
Lenguaje:Inglês
Publicado: Blackwell Science Inc 2006
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2265822/
https://ncbi.nlm.nih.gov/pubmed/16930148
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2567.2006.02460.x
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares